Intraoperative imaging-guided cancer surgery: From current fluorescence molecular imaging methods to future multi-modality imaging technology

Theranostics

Volumn 4, Issue 11, 2014, Pages 1072-1084

  Chi, Chongwei ^a   Du, Yang ^a   Ye, Jinzuo ^a   Kou, Deqiang ^c   Qiu, Jingdan ^c   Wang, Jiandong ^c   Tian, Jie ^a   Chen, Xiaoyuan ^b  

^a INSTITUTE OF AUTOMATION   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Indocyanine green; Intraoperative imaging guided cancer surgery; Multi modality imaging; Near infrared fluorescence; Optical molecular imaging

Indexed keywords

DIAGNOSTIC IMAGING; FLUORESCENCE IMAGING; HUMAN; MEDICAL RESEARCH; MULTIMODAL IMAGING; NEOPLASMS; PATIENT MONITORING; PROCEDURES; TRENDS;

BIOMEDICAL RESEARCH; DIAGNOSTIC IMAGING; HUMANS; MONITORING, INTRAOPERATIVE; MULTIMODAL IMAGING; NEOPLASMS; OPTICAL IMAGING; SURGICAL PROCEDURES, OPERATIVE;

EID: 84906872153     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.9899     Document Type: Review

References (182)

1. Espina C, Porta M, Schuz J, Aguado IH, Percival RV, Dora C, et al. Environmental and occupational interventions for primary prevention of cancer: a cross-sectorial policy framework. Environ Health Perspect. 2013; 121: 420-6
2. Marshall E. Cancer research and the $90 billion metaphor. Science. 2011; 331: 1540-1.
3. [Internet] Varmus H. Professional Judgment Budget 2013. National Cancer Institute http://www.cancer.gov/aboutnci/budget_planning_leg/plan-2013.
4. Kaiser J. The Advocate. Science. 2014; 343: 1460-1.
5. Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013; 10: 507-18.
6. Nguyen QT, Tsien RY. Fluorescence-guided surgery with live molecular navigation - a new cutting edge. Nat Rev Cancer. 2013; 13: 653-62.
7. van Dam GM, Themelis G, Crane LMA, Harlaar NJ, Pleijhuis RG, Kelder W, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med. 2011; 17: 1315-9.
8. van der Vorst JR, Schaafsma BE, Hutteman M, Verbeek FP, Liefers GJ, Hartgrink HH, et al. Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer. 2013;119: 3411-8.
9. Sugie T, Sawada T, Tagaya N, Kinoshita T, Yamagami K, Suwa H, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2013; 20: 2213-8.
10. Troyan SL, Kianzad V, Gibbs-Strauss SL, Gioux S, Matsui A, Oketokoun R, et al. The FLARE((TM)) Intraoperative Near-Infrared Fluorescence Imaging System: A First-in-Human Clinical Trial in Breast Cancer Sentinel Lymph Node Mapping. Ann Surg Oncol. 2009; 16: 2943-52.
11. Lee BT, Hutteman M, Gioux S, Stockdale A, Lin SJ, Ngo LH, et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in perforator flap breast reconstruction. Plast Reconstr Surg. 2010; 126: 1472-81.
12. Mieog JSD, Troyan SL, Hutteman M, Donohoe KJ, Vorst JR, Stockdale A, et al. Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer. Ann Surg Oncol. 2011; 18: 2483-91.
13. Fujiwara M, Mizukami T, Suzuki A, Fukamizu H. Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. J Plast Reconstr Aes. 2009; 62: E373-E8.
14. van der Vorst JR, Schaafsma BE, Verbeek FPR, Swijnenburg RJ, Hutteman M, Liefers GJ, et al. Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma. Brit J Dermatol. 2013; 168: 93-8.
15. Crane LMA, Themelis G, Arts HJG, Buddingh KT, Brouwers AH, Ntziachristos V, et al. Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: First clinical results. Gynecol Oncol. 2011; 120: 291-5.
16. Hutteman M, van der Vorst JR, Gaarenstroom KN, Peters AAW, Mieog JSD, Schaafsma BE, et al. Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer. Am J Obstet Gynecol. 2012; 206: 89.e1-5.
17. Crane LM, Themelis G, Pleijhuis RG, Harlaar NJ, Sarantopoulos A, Arts HJ, et al. Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol. 2011; 13: 1043-9.
18. van der Vorst JR, Hutteman M, Gaarenstroom KN, Peters AAW, Mieog JSD, Schaafsma BE, et al. Optimization of Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Cervical Cancer Patients. Int J Gynecol Cancer. 2011; 21: 1472-8.
19. Nguyen QT, Olson ES, Aguilera TA, Jiang T, Scadeng M, Ellies LG, et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci USA. 2010; 107: 4317-22.
20. Savariar EN, Felsen CN, Nashi N, Jiang T, Ellies LG, Steinbach P, et al. Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides. Cancer Res. 2013; 73: 855-64.
21. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008; 26: 303-12.
22. Newman MI, Samson MC. The application of laser-assisted indocyanine green fluorescent dye angiography in microsurgical breast reconstruction. J Reconstr Microsurg. 2009; 25: 21-6.
23. Cooper G. Early diagnosis of lymphoedema helps to reduce its psychological and social impact. Nurs Times. 2010; 106: 15-7.
24. Suzuki T, Wada S, Eguchi H, Adachi J, Mishima K, Matsutani M, et al. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma Laboratory investigation. J Neurosurg. 2013; 119: 1331-9.
25. Loja MN, Luo Z, Greg Farwell D, Luu QC, Donald PJ, Amott D, et al. Optical molecular imaging detects changes in extracellular pH with the development of head and neck cancer. Int J Cancer. 2013; 132: 1613-23.
26. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005; 12: 211-5.
27. Yokoyama N, Otani T, Hashidate H, Maeda C, Katada T, Sudo N, et al. Real-time detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging: preliminary results of a prospective study. Cancer. 2012; 118: 2813-9.
28. Sevick-Muraca EM. Translation of Near-Infrared Fluorescence Imaging Technologies: Emerging Clinical Applications. Annu Rev Med. 2012; 63: 217-31.
29. Themelis G, Yoo JS, Soh K-S, Schulz R, Ntziachristos V. Real-time intraoperative fluorescence imaging system using light-absorption correction. J Biomed Opt. 2009; 14: 064012.
30. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, et al. A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med. 2012; 18: 829-34.
31. Chance B. Near-infrared images using continuous, phase-modulated, and pulsed light with quantitation of blood and blood oxygenation. Ann N Y Acad Sci. 1998; 838: 29-45.
32. Phillips BT, Lanier ST, Conkling N, Wang ED, Dagum AB, Ganz JC, et al. Intraoperative perfusion techniques can accurately predict mastectomy skin flap necrosis in breast reconstruction: results of a prospective trial. Plast Reconstr Surg. 2012; 129: 778e-88e.
33. Hirche C, Engel H, Kolios L, Cognie J, Hünerbein M, Lehnhardt M, et al. An Experimental Study to Evaluate the Fluobeam 800 Imaging System for Fluorescence-Guided Lymphatic Imaging and Sentinel Node Biopsy. Surg Innov. 2013; 20: 516-23.
34. Nagafuji H, Nakamura T. Feasibility of ICG fluorescence-guided sentinel node biopsy in animal models using the HyperEye Medical System. Ann Surg Oncol. 2011; 18: 2042-7.
35. van der Poel HG, Buckle T, Brouwer OR, Valdés Olmos RA, van Leeuwen FW. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol. 2011; 60: 826-33.
36. Yamashita S-i, Tokuishi K, Anami K, Miyawaki M, Moroga T, Kamei M, et al. Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer. J Thorac Cardiovasc Surg. 2011; 141: 141-4.
37. Spinoglio G, Priora F, Bianchi PP, Lucido FS, Licciardello A, Maglione V, et al. Real-time near-infrared (NIR) fluorescent cholangiography in single-site robotic cholecystectomy (SSRC): a single-institutional prospective study. Surg Endosc. 2013; 27: 2156-62.
38. Borofsky MS, Gill IS, Hemal AK, Marien TP, Jayaratna I, Krane LS, et al. Near-infrared fluorescence imaging to facilitate super-selective arterial clamping during zero-ischaemia robotic partial nephrectomy. BJU Int. 2013; 111: 604-10.
39. Moroga T, Yamashita S-i, Tokuishi K, Miyawaki M, Anami K, Yamamoto S, et al. Thoracoscopic segmentectomy with intraoperative evaluation of sentinel nodes for stage I non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 2011; 18: 89-94.
40. Gotoh K, Yamada T, Ishikawa O, Takahashi H, Eguchi H, Yano M, et al. HOW I DO IT A Novel Image-Guided Surgery of Hepatocellular Carcinoma by Indocyanine Green Fluorescence Imaging Navigation. J Surg Oncol. 2009; 100: 75-9.
41. Mieog JSD, Hutteman M, van der Vorst JR, Kuppen PJK, Que I, Dijkstra J, et al. Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer. Breast Cancer Res Treat. 2011; 128: 679-89.
42. Cahill RA, Anderson M, Wang LM, Lindsey I, Cunningham C, Mortensen NJ. Near-infrared (NIR) laparoscopy for intraoperative lymphatic road-mapping and sentinel node identification during definitive surgical resection of early-stage colorectal neoplasia. Surg Endosc. 2012; 26: 197-204.
43. Liu Y, Njuguna R, Matthews T, Akers WJ, Sudlow GP, Mondal S, et al. Near-infrared fluorescence goggle system with complementary metal-oxide-semiconductor imaging sensor and see-through display. J Biomed Opt. 2013; 18: 101303.
44. Mohebali J, Gottlieb LJ, Agarwal JP. Further validation for use of the retrograde limb of the internal mammary vein in deep inferior epigastric perforator flap breast reconstruction using laser-assisted indocyanine green angiography. J Reconstr Microsurg. 2010; 26: 131-5.
45. Peloso A, Franchi E, Canepa MC, Barbieri L, Briani L, Ferrario J, et al. Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer. HPB (Oxford). 2013; 15: 928-34.
46. Yamamoto M, Sasaguri S, Sato T. Assessing intraoperative blood flow in cardiovascular surgery. Surg today. 2011; 41: 1467-74.
47. Day KE, Beck LN, Deep NL, Kovar J, Zinn KR, Rosenthal EL. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope. 2013; 123: 2681-9.
48. Desai ND, Miwa S, Kodama D, Koyama T, Cohen G, Pelletier MP, et al. A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts. J Thorac Cardiovasc Surg. 2006; 132: 585-94.
49. Perry D, Bharara M, Armstrong DG, Mills J. Intraoperative fluorescence vascular angiography: during tibial bypass. J Diabetes Sci Technol. 2012; 6: 204-8.
50. Sherwinter DA. Identification of anomolous biliary anatomy using near-infrared cholangiography. J Gastrointest Surg. 2012; 16: 1814-5.
51. Sherwinter DA, Gallagher J, Donkar T. Intra-operative transanal near infrared imaging of colorectal anastomotic perfusion: a feasibility study. Colorectal Dis. 2013; 15: 91-6.
52. Gray D, Kim E, Cotero V, Staudinger V, Yazdanfar S, Tan Hehir C. A compact fluorescence and white light imaging system for intraoperative visualization of nerves. Proc SPIE. 2012;: 8207.
53. Keereweer S, Mol IM, Vahrmeijer AL, Van Driel PB, de Jong B, Robert J, et al. Dual wavelength tumor targeting for detection of hypopharyngeal cancer using near-infrared optical imaging in an animal model. Int J Cancer. 2012; 131: 1633-40.
54. Wapnir I, Dua M, Kieryn A, Paro J, Morrison D, Kahn D, et al. Intraoperative Imaging of Nipple Perfusion Patterns and Ischemic Complications in Nipple-Sparing Mastectomies. Ann Surg Oncol. 2014; 21: 100-6.
55. Hutteman M, Choi HS, Mieog JS, van der Vorst JR, Ashitate Y, Kuppen PJ, et al. Clinical translation of ex vivo sentinel lymph node mapping for colorectal cancer using invisible near-infrared fluorescence light. Ann Surg Oncol. 2011; 18: 1006-14.
56. van der Vorst JR, Schaafsma BE, Verbeek FPR, Keereweer S, Jansen JC, van der Velden LA, et al. Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients. Oral Oncol. 2013; 49: 15-9.
57. Crane LMA, Themelis G, Pleijhuis RG, Harlaar NJ, Sarantopoulos A, Arts HJG, et al. Intraoperative Multispectral Fluorescence Imaging for the Detection of the Sentinel Lymph Node in Cervical Cancer: A Novel Concept. Mol Imaging Biol. 2011; 13: 1043-9.
58. Kijanka M, Warnders FJ, El Khattabi M, Lub-de Hooge M, van Dam GM, Ntziachristos V, et al. Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery. Eur J Nucl Med Mol Imaging. 2013; 40: 1718-29.
59. Pleijhuis RG, Langhout GC, Helfrich W, Themelis G, Sarantopoulos A, Crane LMA, et al. Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: Assessing intraoperative techniques in tissue-simulating breast phantoms. Eur J Surg Oncol. 2011; 37: 32-9.
60. Chi C, Ye J, Ding H, He D, Huang W, Zhang GJ, et al. Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation. PloS One. 2013; 8: e83927.
61. Jafari MD, Lee KH, Halabi WJ, Mills SD, Carmichael JC, Stamos MJ, et al. The use of indocyanine green fluorescence to assess anastomotic perfusion during robotic assisted laparoscopic rectal surgery. Surg Endosc. 2013; 27: 3003-8.
62. Yokoyama J, Fujimaki M, Ohba S, Anzai T, Yoshii R, Ito S, et al. A feasibility study of NIR fluorescent image-guided surgery in head and neck cancer based on the assessment of optimum surgical time as revealed through dynamic imaging. Onco Targets Ther. 2013; 6: 325-30.
63. Oh G, Yoo SW, Jung Y, Ryu YM, Park Y, Kim SY, et al. Intravital imaging of mouse colonic adenoma using MMP-based molecular probes with multi-channel fluorescence endoscopy. Biomed Opt Express. 2014; 5: 1677-89.
64. Matsui A, Tanaka E, Choi HS, Winer JH, Kianzad V, Gioux S, et al. Real-time intra-operative near-infrared fluorescence identification of the extrahepatic bile ducts using clinically available contrast agents. Surgery. 2010; 148: 87-95.
65. Matsui A, Tanaka E, Choi HS, Kianzad V, Gioux S, Lomnes SJ, et al. Real-time, near-infrared, fluorescence-guided identification of the ureters using methylene blue. Surgery. 2010; 148: 78-86.
66. Venugopal V, Park M, Ashitate Y, Neacsu F, Kettenring F, Frangioni JV, et al. Design and characterization of an optimized simultaneous color and near-infrared fluorescence rigid endoscopic imaging system. Biomed Opt Express. 2013; 18: 126018.
67. Glatz J, Varga J, Garcia-Allende PB, Koch M, Greten FR, Ntziachristos V. Concurrent video-rate color and near-infrared fluorescence laparoscopy. J Biomed Opt. 2013; 18: 101302.
68. Ali T, Choyke PL, Kobayashi H. Endoscopic molecular imaging of cancer. Future Oncol. 2013; 9: 1501-13.
69. Ale A, Ermolayev V, Herzog E, Cohrs C, de Angelis MH, Ntziachristos V. FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography. Nat methods. 2012; 9: 615-20.
70. Xie J, Chen K, Huang J, Lee S, Wang JH, Gao J, et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials. 2010; 31: 3016-22.
71. Ewelt C, Floeth FW, Felsberg J, Steiger HJ, Sabel M, Langen KJ, et al. Finding the anaplastic focus in diffuse gliomas: The value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosur. 2011; 113: 541-7.
72. Si K, Fiolka R, Cui M. Fluorescence imaging beyond the ballistic regime by ultrasound-pulse-guided digital phase conjugation. Nat Photonics. 2012; 6: 657-61.
73. Motomura K, Inaji H, Komoike Y, Hasegawa Y, Kasugai T, Noguchi S, et al. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol. 2001; 76: 95-9.
74. Radovanovic Z, Golubovic A, Plzak A, Stojijkovic B, Radovanovic D. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer. Eur J Surg Oncol. 2004; 30: 913-7.
75. van de Ven S, Wiethoff A, Nielsen T, Brendel B, van der Voort M, Nachabe R, et al. A Novel Fluorescent Imaging Agent for Diffuse Optical Tomography of the Breast: First Clinical Experience in Patients. Mol Imaging Biol 2010; 12: 343-8.
76. Bredell MG. Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer - preliminary experience. Head Neck Oncol. 2010; 2: 31.
77. Murawa D, Hirche C, Dresel S, Hunerbein M. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg. 2009; 96: 1289-94.
78. Chiu CC. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence (Br J Surg 2009; 96: 1289-1294). Br J Surg. 2010; 97: 455.
79. Sugie T, Kassim KA, Takeuchi M, Hashimoto T, Yamagami K, Masai Y, et al. A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer. Cancers (Basel). 2010; 2: 713-20.
80. Hirche C, Murawa D, Mohr Z, Kneif S, Hunerbein M. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat. 2010; 121: 373-8.
81. Noura S, Ohue M, Seki Y, Tanaka K, Motoori M, Kishi K, et al. Feasibility of a Lateral Region Sentinel Node Biopsy of Lower Rectal Cancer Guided by Indocyanine Green Using a Near-Infrared Camera System. Ann Surg Oncol. 2010; 17: 144-51.
82. Hutteman M, Mieog JSD, van der Vorst JR, Liefers GJ, Putter H, Lowik CWGM, et al. Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat. 2011; 127: 163-70.
83. Polom K, Murawa D, Nowaczyk P, Rho YS, Murawa P. Breast cancer sentinel lymph node mapping using near infrared guided indocyanine green and indocyanine green--human serum albumin in comparison with gamma emitting radioactive colloid tracer. Eur J Surg Oncol. 2012; 38: 137-42.
84. Schaafsma BE, Verbeek FP, Rietbergen DD, van der Hiel B, van der Vorst JR, Liefers GJ, et al. Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg. 2013; 100: 1037-44.
85. Namikawa K, Yamazaki N. Sentinel lymph node biopsy guided by indocyanine green fluorescence for cutaneous melanoma. Eur J Dermatol. 2011; 21: 184-90.
86. Polom K, Murawa D, Rho YS, Spychala A, Murawa P. Skin melanoma sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green and indocyanine green with human serum albumin. Br J Dermatol. 2012; 166: 682-3.
87. Gilmore DM, Khullar OV, Gioux S, Stockdale A, Frangioni JV, Colson YL, et al. Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann Surg Oncol. 2013; 20: 2357-63.
88. Namikawa K, Tsutsumida A, Tanaka R, Kato J, Yamazaki N. Limitation of indocyanine green fluorescence in identifying sentinel lymph node prior to skin incision in cutaneous melanoma. Int J Clin Oncol. 2014; 19: 198-203.
89. van der Vorst J, Schaafsma B, Verbeek F, Swijnenburg R, Hutteman M, Liefers G, et al. Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma. Brit J Dermatol. 2013; 168: 93-8.
90. Uhara H, Yamazaki N, Takata M, Inoue Y, Sakakibara A, Nakamura Y, et al. Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanoma. J Dermatol. 2012; 39: 336-8.
91. Kermani AT, Bagheri R, Tehranian S, Shojaee P, Sadeghi R, Krag DN. Accuracy of sentinel node biopsy in the staging of non-small cell lung carcinomas: Systematic review and meta-analysis of the literature. Lung Cancer. 2013; 80: 5-14.
92. Imai K, Minamiya Y, Saito H, Nakagawa T, Ito M, Ono T, et al. Detection of pleural lymph flow using indocyanine green fluorescence imaging in non-small cell lung cancer surgery: a preliminary study. Surg Today. 2013; 43: 249-54.
93. Gilmore DM, Khullar OV, Jaklitsch MT, Chirieac LR, Frangioni JV, Colson YL. Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging. J Thorac Cardiov Sur. 2013; 146: 562-9.
94. Yamashita S, Tokuishi K, Miyawaki M, Anami K, Moroga T, Takeno S, et al. Sentinel node navigation surgery by thoracoscopic fluorescence imaging system and molecular examination in non-small cell lung cancer. Ann Surg Oncol. 2012; 19: 728-33.
95. Moroga T, Yamashita S, Tokuishi K, Miyawaki M, Anami K, Yamamoto S, et al. Thoracoscopic Segmentectomy with Intraoperative Evaluation of Sentinel Nodes for Stage I Non-Small Celll Lung Cancer. Ann Thorac Cardiovas. 2012; 18: 89-94.
96. Yamashita S, Tokuishi K, Anami K, Miyawaki M, Moroga T, Kamei M, et al. Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer. J Thorac Cardiov Sur. 2011; 141: 141-4.
97. Ito N, Fukuta M, Tokushima T, Nakai K, Ohgi S. Sentinel node navigation surgery using indocyanine green in patients with lung cancer. Surg Today. 2004; 34: 581-5.
98. Sugi K, Fukuda M, Nakamura H, Kaneda Y. Comparison of three tracers for detecting sentinel lymph nodes in patients with clinical N0 lung cancer. Lung Cancer. 2003; 39: 37-40.
99. Kubota K, Yoshida M, Kuroda J, Okada A, Ohta K, Kitajima M. Application of the HyperEye Medical System for esophageal cancer surgery: a preliminary report. Surg Today. 2013; 43: 215-20.
100. Takeuchi H, Kitagawa Y. New Sentinel Node Mapping Technologies for Early Gastric Cancer. Ann Surg Oncol. 2013; 20: 522-32.
101. Can MF, Yagci G, Cetiner S. Systematic Review of Studies Investigating Sentinel Node Navigation Surgery and Lymphatic Mapping for Gastric Cancer. J Laparoendosc Adv Surg Tech A. 2013; 23: 651-62.
102. Lee JH, Park DJ, Kim YH, Shin CM, Lee HS, Kim HH. Clinical Implementations of Preoperative Computed Tomography Lymphography in Gastric Cancer: A Comparison with Dual Tracer Methods in Sentinel Node Navigation Surgery. Ann Surg Oncol. 2013; 20: 2296-303.
103. Takeuchi H, Kitagawa Y. Sentinel Node Navigation Surgery in Patients with Early Gastric Cancer. Digest Surg. 2013; 30: 104-11.
104. Bok GH, Kim YJ, Jin SY, Chun CG, Lee TH, Kim HG, et al. Endoscopic submucosal dissection with sentinel node navigation surgery for early gastric cancer. Endoscopy. 2012; 44: 953-6.
105. Fujita T, Seshimo A, Kameoka S. Detection of Sentinel Nodes in Gastric Cancer by Indocyanine Green Fluorescence Imaging. Hepatogastroenterology. 2012; 59: 2213-6.
106. Wang Z, Dong ZY, Chen JQ, Liu JL. Diagnostic Value of Sentinel Lymph Node Biopsy in Gastric Cancer: A Meta-Analysis. Ann Surg Oncol. 2012; 19: 1541-50.
107. Polom K, Murawa D, Rho YS, Nowaczyk P, Hunerbein M, Murawa P. Current Trends and Emerging Future of Indocyanine Green Usage in Surgery and Oncology A Literature Review. Cancer. 2011; 117: 4812-22.
108. Kelder W, Nimura H, Takahashi N, Mitsumori N, van Dam GM, Yanaga K. Sentinel node mapping with indocyanine green (ICG) and infrared ray detection in early gastric cancer: An accurate method that enables a limited lymphadenectomy. Eur J Surg Oncol. 2010; 36: 552-8.
109. Tajima Y, Yamazaki K, Masuda Y, Kato M, Yasuda D, Aoki T, et al. Sentinel Node Mapping Guided by Indocyanine Green Fluorescence Imaging in Gastric Cancer. Ann Surg. 2009; 249: 58-62.
110. Kusano M, Tajima Y, Yamazaki K, Kato M, Watanabe M, Miwa M. Sentinel node mapping guided by indocyanine green fluorescence imaging: A new method for sentinel node navigation surgery in gastrointestinal cancer. Digest Surg. 2008; 25: 103-8.
111. Ohdaira H, Nimura H, Mitsumori N, Takahashi N, Kashiwagi H, Yanaga K. Validity of modified gastrectomy combined with sentinel node navigation surgery for early gastric cancer. Gastric Cancer. 2007; 10: 117-22.
112. Morita D, Tsuda H, Ichikura T, Kimura M, Aida S, Kosuda S, et al. Analysis of sentinel node involvement in gastric cancer. Clin Gastroenterol Hepatol. 2007; 5: 1046-52.
113. Ishikawa K, Yasuda K, Shiromizu A, Etoh T, Shiraishi N, Kitano S. Laparoscopic sentinel node navigation achieved by infrared ray electronic endoscopy system in patients with gastric cancer. Surg Endosc. 2007; 21: 1131-4.
114. Nakamura Y, Fujisawa Y, Nakamura Y, Maruyama H, Furuta J, Kawachi Y, et al. Improvement of the sentinel lymph node detection rate of cervical sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in head and neck skin cancer. J Dermatol. 2013; 40: 453-7.
115. Schaafsma BE, van der Vorst JR, Gaarenstroom KN, Peters AA, Verbeek FP, de Kroon CD, et al. Randomized comparison of near-infrared fluorescence lymphatic tracers for sentinel lymph node mapping of cervical cancer. Gynecol Oncol. 2012; 127: 126-30.
116. Furukawa N, Oi H, Yoshida S, Shigetomi H, Kanayama S, Kobayashi H. The usefulness of photodynamic eye for sentinel lymph node identification in patients with cervical cancer. Tumori. 2010; 96: 936-40.
117. Rossi EC, Ivanova A, Boggess JF. Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study. Gynecol Oncol. 2012; 124: 78-82.
118. Schaafsma BE, Verbeek FP, van der Vorst JR, Hutteman M, Kuppen PJ, Frangioni JV, et al. Ex vivo sentinel node mapping in colon cancer combining blue dye staining and fluorescence imaging. J Surg Res. 2013; 183: 253-7.
119. van der Pas MHGM, Ankersmit M, Stockmann HBAC, Silvis R, van Grieken NCT, Bril H, et al. Laparoscopic Sentinel Lymph Node Identification in Patients with Colon Carcinoma Using a Near-Infrared Dye: Description of a New Technique and Feasibility Study. J Laparoendosc Adv Surg Tech A. 2013; 23: 367-71.
120. Hirche C, Mohr Z, Kneif S, Doniga S, Murawa D, Strik M, et al. Ultrastaging of colon cancer by sentinel node biopsy using fluorescence navigation with indocyanine green. Int J Colorectal Dis. 2012; 27: 319-24.
121. Ankersmit M, van der Pas MH, van Dam DA, Meijerink WJ. Near infrared fluorescence lymphatic laparoscopy of the colon and mesocolon. Colorectal Dis. 2011; 13 Suppl 7: 70-3.
122. Rossi EC, Ivanova A, Boggess JF. Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility study. Gynecologic Oncology. 2012; 124: 78-82.
123. Holloway RW, Bravo RAM, Rakowski JA, James JA, Jeppson CN, Ingersoll SB, et al. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: A comparison of colorimetric and fluorescence imaging. Gynecol Oncol. 2012; 126: 25-9.
124. Levinson KL, Mahdi H, Escobar PF. Feasibility and Optimal Dosage of Indocyanine Green Fluorescence for Sentinel Lymph Node Detection Using Robotic Single-Site Instrumentation: Preclinical Study. J Minim Invas Gyn. 2013; 20: 691-6.
125. Schaafsma BE, Verbeek FPR, Peters AAW, van der Vorst JR, de Kroon CD, van Poelgeest MIE, et al. Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers. BJOG. 2013; 120: 758-64.
126. Verbeek FPR, Troyan SL, Mieog JSD, Liefers GJ, Moffitt LA, Rosenberg M, et al. Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience. Breast Cancer Res Treat. 2014; 143: 333-42.
127. Morton DL, Bostick PJ. Will the true sentinel node please stand? Ann Surg Oncol. 1999; 6: 12-4.
128. Buckle T, van Leeuwen AC, Chin PT, Janssen H, Muller SH, Jonkers J, et al. A self-assembled multimodal complex for combined pre-and intraoperative imaging of the sentinel lymph node. Nanotechnology. 2010; 21: 355101.
129. Liu Y, Zhao YM, Akers W, Tang ZY, Fan J, Sun HC, et al. First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study. Transl Res. 2013; 162: 324-31.
130. Satou S, Ishizawa T, Masuda K, Kaneko J, Aoki T, Sakamoto Y, et al. Indocyanine green fluorescent imaging for detecting extrahepatic metastasis of hepatocellular carcinoma. J Gastroenterol. 2013; 48: 1136-43.
131. Morita Y, Sakaguchi T, Unno N, Shibasaki Y, Suzuki A, Fukumoto K, et al. Detection of hepatocellular carcinomas with near-infrared fluorescence imaging using indocyanine green: its usefulness and limitation. Int J Clin Oncol. 2013; 18: 232-41.
132. Uchiyama K, Ueno M, Ozawa S, Kiriyama S, Shigekawa Y, Hirono S, et al. Combined intraoperative use of contrast-enhanced ultrasonography imaging using a sonazoid and fluorescence navigation system with indocyanine green during anatomical hepatectomy. Langenbeck Arch Surg. 2011; 396: 1101-7.
133. Ishizawa T, Fukushima N, Shibahara J, Masuda K, Tamura S, Aoki T, et al. Real-Time Identification of Liver Cancers by Using Indocyanine Green Fluorescent Imaging. Cancer. 2009; 115: 2491-504.
134. Kawaguchi Y, Aoki T, Ishizawa T, Arita J, Satou S, Kaneko J, et al. Education and imaging: Hepatobiliary and pancreatic: Identification of recurrent hepatocellular carcinoma by intraoperative fluorescent imaging. J Gastroenterol Hepatol. 2013; 28: 587.
135. Ishizawa T, Masuda K, Urano Y, Kawaguchi Y, Satou S, Kaneko J, et al. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol. 2014; 21: 440-8.
136. Sturm MB, Joshi BP, Lu SY, Piraka C, Khondee S, Elmunzer BJ, et al. Targeted Imaging of Esophageal Neoplasia with a Fluorescently Labeled Peptide: First-in-Human Results. Sci Transl Med. 2013; 5: 184ra61.
137. Yang LL, Sajja HK, Cao ZH, Qian WP, Bender L, Marcus AI, et al. uPAR-targeted Optical Imaging Contrasts as Theranostic Agents for Tumor Margin Detection. Theranostics. 2014; 4: 106-18.
138. Scheuer W, van Dam GM, Dobosz M, Schwaiger M, Ntziachristos V. Drug-based optical agents: infiltrating clinics at lower risk. Sci Transl Med. 2012; 4: 134ps11.
139. [Internet] van Dam GM. VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer. http://clinicaltrials.gov/show/NCT01508572
140. Thorek DLJ, Riedl CC, Grimm J. Clinical Cerenkov Luminescence Imaging of F-18-FDG. J Nucl Med. 2014; 55: 95-8.
141. Laverman P, Sosabowski JK, Boerman OC, Oyen WJ. Radiolabelled peptides for oncological diagnosis. Eur J Nucl Med Mol Imaging. 2012; 39 Suppl 1: S78-92.
142. Carey JN, Rommer E, Sheckter C, Minneti M, Talving P, Wong AK, et al. Simulation of plastic surgery and microvascular procedures using perfused fresh human cadavers. J Plast Reconstr Aesthet Surg. 2014; 67: e42-8.
143. Mieog JSD, Hutteman M, van der Vorst JR, Kuppen PJ, Que I, Dijkstra J, et al. Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer. Breast cancer Res Treat. 2011; 128: 679-89.
144. Sugie T, Kassim KA, Takeuchi M, Hashimoto T, Yamagami K, Masai Y, et al. A novel method for sentinel lymph node biopsy by indocyanine green fluorescence technique in breast cancer. Cancers. 2010; 2: 713-20.
145. Kaushal S, McElroy MK, Luiken GA, Talamini MA, Moossa AR, Hoffman RM, et al. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg. 2008; 12: 1938-50.
146. Tran Cao HS, Kaushal S, Metildi CA, Menen RS, Lee C, Snyder CS, et al. Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer. Hepatogastroenterology. 2012; 59: 1994-9.
147. Hutteman M, Mieog JS, van der Vorst JR, Dijkstra J, Kuppen PJ, van der Laan AM, et al. Intraoperative near-infrared fluorescence imaging of colorectal metastases targeting integrin alpha(v)beta(3) expression in a syngeneic rat model. Eur J Surg Oncol. 2011; 37: 252-7.
148. Oliveira S, van Dongen GA, Stigter-van Walsum M, Roovers RC, Stam JC, Mali W, et al. Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody. Mol Imaging. 2012; 11: 33-46.
149. Wu AP, Whitney MA, Crisp JL, Friedman B, Tsien RY, Nguyen QT. Improved facial nerve identification with novel fluorescently labeled probe. Laryngoscope. 2011; 121: 805-10.
150. Olson ES, Whitney MA, Friedman B, Aguilera TA, Crisp JL, Baik FM, et al. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Integr Biol (Camb). 2012; 4: 595-605.
151. Olson ES, Jiang T, Aguilera TA, Nguyen QT, Ellies LG, Scadeng M, et al. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci U S A. 2010; 107: 4311-6.
152. Deu E, Verdoes M, Bogyo M. New approaches for dissecting protease functions to improve probe development and drug discovery. Nat Struct Mol Biol. 2012; 19: 9-16..
153. Blum G, Weimer RM, Edgington LE, Adams W, Bogyo M. Comparative assessment of substrates and activity based probes as tools for non-invasive optical imaging of cysteine protease activity. PloS One. 2009; 4: e6374.
154. Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol. 2007; 3: 668-77.
155. Gleysteen JP, Duncan RD, Magnuson JS, Skipper JB, Zinn K, Rosenthal EL. Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. Cancer Ther. 2007; 6: 1181-5.
156. Lee SB, Hassan M, Fisher R, Chertov O, Chernomordik V, Kramer-Marek G, et al. Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res. 2008; 14: 3840-9.
157. Withrow KP, Newman JR, Skipper JB, Gleysteen JP, Magnuson JS, Zinn K, et al. Assessment of bevacizumab conjugated to Cy5. 5 for detection of head and neck cancer xenografts. Technol Cancer Res Treat. 2008; 7: 61-6.
158. Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL. Use of Panitumumab-IRDye800 to Image Microscopic Head and Neck Cancer in an Orthotopic Surgical Model. Ann Surg Oncol. 2012; 19: 3879-87.
159. Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores. Breast Cancer Res. 2012; 14: R61.
160. van Scheltinga AGTT, van Dam GM, Nagengast WB, Ntziachristos V, Hollema H, Herek JL, et al. Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies. J Nucl Med. 2011; 52: 1778-85.
161. Ye Y, Chen X. Integrin targeting for tumor optical imaging. Theranostics. 2011; 1: 102-26.
162. Chen K, Xie J, Chen X. RGD-human serum albumin conjugates as efficient tumor targeting probes. Mol Imaging. 2009; 8: 65-73.
163. Smith BR, Cheng Z, De A, Koh AL, Sinclair R, Gambhir SS. Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. Nano Lett. 2008; 8: 2599-606.
164. Li Y, Li Z, Wang X, Liu F, Cheng Y, Zhang B, et al. In vivo cancer targeting and imaging-guided surgery with near infrared-emitting quantum dot bioconjugates. Theranostics. 2012; 2: 769-76.
165. Weissleder R, Tung CH, Mahmood U, Bogdanov A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 1999; 17: 375-8.
166. Zhu L, Xie J, Swierczewska M, Zhang F, Quan QM, Ma Y, et al. Real-Time Video Imaging of Protease Expression In Vivo. Theranostics. 2011; 1: 18-27.
167. Wunderbaldinger P, Turetschek K, Bremer C. Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe. Eur Radiol. 2003; 13: 2206-11.
168. Myochin T, Hanaoka K, Komatsu T, Terai T, Nagano T. Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene. J Am Chem Soc. 2012; 134: 13730-7.
169. Barber PA, Rushforth D, Agrawal S, Tuor UI. Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia. BMC Neurosci. 2012; 13: 76.
170. Lee CM, Jang D, Cheong SJ, Jeong MH, Kim EM, Kim DW, et al. Optical imaging of MMP expression and cancer progression in an inflammation-induced colon cancer model. Int J Cancer. 2012; 131: 1846-53.
171. Ryu JH, Lee A, Huh MS, Chu J, Kim K, Kim BS, et al. Measurement of MMP Activity in Synovial Fluid in Cases of Osteoarthritis and Acute Inflammatory Conditions of the Knee Joints Using a Fluorogenic Peptide Probe-Immobilized Diagnostic Kit. Theranostics. 2012; 2: 198-206.
172. Azhdarinia A, Wilganowski N, Robinson H, Ghosh P, Kwon S, Lazard ZW, et al. Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide. Bioorgan Med Chem. 2011; 19: 3769-76.
173. Ryu JH, Lee A, Lee S, Ahn CH, Park JW, Leary JF, et al. One-step detection of matrix metalloproteinase activity using a fluorogenic peptide probe-immobilized diagnostic kit. Bioconjug Chem. 2010; 21: 1378-84.
174. Keereweer S, Kerrebijn JD, van Driel PB, Xie B, Kaijzel EL, Snoeks TJ, et al. Optical image-guided surgery--where do we stand? Mol Imaging Biol. 2011; 13: 199-207.
175. Thorek DLJ, Ogirala A, Beattie BJ, Grimm J. Quantitative imaging of disease signatures through radioactive decay signal conversion. Nat Med. 2013; 19: 1345-50.
176. Chin PTK, Welling MM, Meskers SCJ, Olmos RAV, Tanke H, van Leeuwen FWB. Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence. Eur J Nucl Med Mol Imaging. 2013; 40: 1283-91.
177. Liu HG, Carpenter CM, Jiang H, Pratx G, Sun C, Buchin MP, et al. Intraoperative Imaging of Tumors Using Cerenkov Luminescence Endoscopy: A Feasibility Experimental Study. J Nucl Med. 2012; 53: 1579-84.
178. Luo T, Huang P, Gao G, Shen G, Fu S, Cui D, et al. Mesoporous silica-coated gold nanorods with embedded indocyanine green for dual mode X-ray CT and NIR fluorescence imaging. Opt Express. 2011; 19: 17030-9.
179. Yuasa Y, Seike J, Yoshida T, Takechi H, Yamai H, Yamamoto Y, et al. Sentinel Lymph Node Biopsy Using Intraoperative Indocyanine Green Fluorescence Imaging Navigated with Preoperative CT Lymphography for Superficial Esophageal Cancer. Ann Surg Oncol. 2012; 19: 486-93.
180. Chen YJ, Wu SC, Chen CY, Tzou SC, Cheng TL, Huang YF, et al. Peptide-based MRI contrast agent and near-infrared fluorescent probe for intratumoral legumain detection. Biomaterials. 2014; 35: 304-15.
181. Zhang F, Zhu L, Huang X, Niu G, Chen X. Differentiation of reactive and tumor metastatic lymph nodes with diffusion-weighted and SPIO-enhanced MRI. Mol Imaging Biol. 2013; 15: 40-7.
182. Huang X, Zhang F, Lee S, Swierczewska M, Kiesewetter DO, Lang L, et al. Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. Biomaterials. 2012; 33: 4370-8.